Startup | January 27, 2022
Botanical Solution Inc. raises $6.1 million in Series A
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
The current annual U.S. market for prazosin hydrochloride 1mg, 2mg, 5mg strengths is approximately US $ 54 million, according to IQVIA/IMS Health
In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
Glenmark’s Ropivacaine Hydrochloride Injection USP is bioequivalent and therapeutically equivalent to the reference listed drug Naropin Injection of Fresenius Kabi USA
The combination is approved for advanced endometrial carcinoma that is pMMR or not MSI-H and has progressed after prior systemic therapy
Acquisition expands Novo Nordisk’s leadership in obesity-related comorbidities and metabolic diseases
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Subscribe To Our Newsletter & Stay Updated
